Use of miniature pig for biomedical research, with reference to toxicologic studies

Journal of Toxicologic Pathology

Volumn 20, Issue 3, 2007, Pages 125-132

  Nunoya, Tetsuo ^a   Shibuya, Kazumoto ^a   Saitoh, Toshiki ^a   Yazawa, Hajime ^a   Nakamura, Keigo ^a   Baba, Yasuko ^a   Hirai, Takuya ^a  

^a NIPPON INSTITUTE FOR BIOLOGICAL SCIENCE   (Japan)

Author keywords

Animal model; Biomedical research; Miniature pig; Toxicology

Indexed keywords

EID: 35548955101     PISSN: 09149198     EISSN: None     Source Type: Journal    
DOI: 10.1293/tox.20.125     Document Type: Review

References (61)

1. Yamada K, Yazawa K, Shimizu A, Iwanaga T, Hisashi Y, Nuhn M, O'Malley P, Nobori S, Vagefi PA, Patience C, Fishman J, Cooper DKC, Hawley RJ, Greenstein J, Schuurman Henk-J, Awward M, Sykes M, and Sachs DH. Marked prolongation of porcine renal xenograft survival in baboons through the use of α1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vasculized thymic fissue. Nature Med. 11: 32-34. 2005.
2. Vodicka P, Smetana K Jr, Dvorankova B, Emerick T, Xu YZ, Ourednik J, Ourednik V, and Motlik J. The miniature pig as an animal model in biomedical research. Ann N Y Acad Sci. 1049: 161-171. 2005.
3. Larsen MO and Rolin B. Use of the Göttingen minipig as a model of diabetes, with special focus on type 1 diabetes research. ILAR Journal. 45: 303-313. 2004.
4. Cynthia P and Smith MS. Information Resources on Swine in Biomedical Research. AWIC Resource Series No. 11. United States Department of Agriculture, MD. 2000.
5. Swindle MM, Smith AC, Laber-Laird K, and Dungan L. Farm animals in biomedical research - Part one. Swine in biomedical research: Management and models. ILAR Journal Online. 36:1-12. 1994.
6. Lawhorn B. Diseases and conditions of miniature pet pigs. In: Care and Management of Miniature Pet Pigs, 1st ed. DE Reeves (ed). Veterinary Practice Publishing Company. Santa Barbara, CA. 77-100. 1993.
7. Swindle MM, Horneffer PJ, Gardner TJ, Gott VL, Hall TS, Sturat RS, Baumgartner WA, Borkon AM, Galloway E, and Reitz BA. Anatomic and anesthetic considerations in experimental cardio-pulmonary surgery in swine. Lab Anim Sci. 36: 357-361. 1986
8. Hughes HC. Swine in cardiovascular research. Lab Anim Sci. 36: 348-350. 1986.
9. Smith AC, Spinale FG, and Swindle MM. Cardiac function and morphology of Hanford miniature swine and Yucatan miniature and micro swine. Lab Anim Sci. 40: 47-50. 1990.
10. Reitman JS, Mahley RW, and Fry DL. Yucatan miniature swine as a model for diet-induced atherosclerosis. Atherosclerosis. 43: 119-132, 1982.
11. Tanigawa M, Akaike I, Adachi J, Shinkai H, Tokoi K, Uchiyama T, Ibaraki T, and Mochizuki K. Göttingen miniature swine as a model for diet-induced atherosclerosis. Jikken Dobutsu. 35: 47-57. 1986 (In Japanese).
12. Kurihara-Bergstrom T, Woodworth M, Feisullin S, and Beall P. Characterization of the Yucatan miniature pig skin and small intestine for pharmaceutical applications. Lab Amin Sci. 36: 396-399. 1986.
13. Kerrigan CL, Zelt RG, Thompson JG, and Diano E. The pig as an experimental animal in plastic surgery research for the study of skin flaps, myocutaneous flaps and fasciocutaneous flaps. Lab Anim. Sci. 36: 408-412. 1986.
14. Shulman RJ, Henning SJ, and Nichols BL. The miniature pig as an animal model for the study of intestinal enzyme development. Pediatr Res. 23: 311-315. 1988.
15. Vodicka P, Smetana K Jr, Dvorankova B, Emerick T, Xu YZ, Ourednik J, Ourednik V, and Motlik J. The miniature pig as an animal model in biomedical research. Ann N Y Acad Sci. 1049: 161-171. 2005.
16. Panepinto LM, Phillips RW, Wheeler LR, and Will DH. The Yucatan minature pig as a laboratory animal. Lab Anim Sci. 28: 308-313. 1978.
17. Misfeldt ML and Grimm DR. Sinclair miniature swine: an animal model of human melanoma. Vet Immunol Immunopathol. 43: 167-175. 1994.
18. Oshima S, Sato H, Nagase S, Hirohashi K, and Omi H. A new strain of small-sized pig originated from a Chinese breed. Jikken Doubutsu. 22 (Suppl): 253-259. 1973 (In Japanese).
19. Nakanishi Y. Body measurements and some characteristics of inbred CLAWN miniature pigs. Jpn J Swine Sci. 28: 211-218. 1981.
20. Kano M, Toyoshi T, Iwasaki S, Kato M, Shimizu M, and Ota T. QT PRODACT: Usability of miniature pigs in safety pharmacology studies: assessment for drug-induced QT interval prolongation. J Pharmacol Sci. 99: 501-511. 2005.
21. Panepinto LM and Phillips RW. The Yucatan miniature pig: characterization and utilization in biomedical research. Lab Anim Sci. 36: 344-347. 1986.
22. Board on Scinece and Technology for International Development National Research Council. MICROLIVESTOCK Little-Known Small Animal with a Promising Economic Future. National Academy Press, Washington D.C. 63-72. 1991.
23. Jones DH and Amoss MS Jr. Cell mediated immune response in miniature Sinclair swine bearing cutaneous melanomas. Can J Comp Med. 46: 209-211. 1982.
24. Rand MS. Farm animals as models for biomedical research. Lecture notes for 10/16/02. University of Arizona, Tucson. 2002.
25. Svendsen O. The minipig in toxicology. Exp Toxicol Pathol. 57: 335-339. 2006.
26. Nakanishi Y, Tojo H, Hirohama K, Ogawa K, and Yamanouchi C. Some aspects of growth, reproduction, lactational performance and semen characteristics in miniature pigs. Bull Fac Agric, Kagoshima Univ. 31: 53-58. 1981.
27. Komatsu K, Akutsu Y, Kanai T, Saitoh, Sakamoto Y, Shinkai H, Komatsu M, Yazawa H, and Mizutani M. Establishment and reproductive performance of NIBS minipigs. Proceedings of the Japanese Congress of Laboratory Animal Science and Technology 2001, Yokohama (in Japanese).
28. Anzenbacherová E, Anzenbacher P, Svoboda Z, Ulrichová J, Kvêtina J, Zoulová J, Perlik F, and Martinkozá J. Minipig as a model for drug metabolism in man: comparison of in vitro and in vivo metabolism of propafenone. Biomed Papaers. 147: 155-159. 2003.
29. Zuber R, Anzenbacherova E, and Anzenbacher P. Cytochromes P450 and experimental models of drug metabolism. J Cell Mol Med. 6: 189-198. 2000.
30. Anzenbacher P, Soucek P, Anzenbacherová E, Gut I, Hruby K, Svoboda Z, and Kvetina J. Presence and activity of cytochrome P450 isoforms in minipig liver microsomes. Comparison with human liver samples. Drug Metab Dispos. 26: 56-59. 1998.
31. Soucek P, Zuber R, Anzenbacherová E, Anzenbacher P, and Guengerich FP. Minipig cytochrome P450 3A, 2A and 2C enzymes have similar properties to human analogs. BMC Pharmacol. 1: 11-15. 2001.
32. Daher GC, Lawson KD, Tallmadge DH, Vanderploeg P, and Miller KW. Disposition of ingested olestra in weanling mini-pigs. Food Chem Toxicol. 34: 693-699. 1996.
33. Oberle RL, Das H, Wong SL, Chan KK, and Sawchuk RJ. Pharmacokinetics and metabolism of diclofenac sodium in Yucatan miniature pigs. Pharm. Res. 11: 698-703. 1994.
34. Dorman DC, Dye JA, Nassise MP, Ekuta J, Bolon B, and Medinsky MA. Acute methanol toxicity in minipigs. Fundam Appl Toxicol. 20: 341-347. 1993.
35. Lavker RM, Dong G, Zheng PS, and Murphy GF. Hairless micropig skin. A novel model for studies of cutaneous biology. Am J Pathol. 138: 687-697. 1991.
36. Simon GA and Maibach HI. The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations - an overview. Skin Pharmacol Appl Skin Physiol. 13: 229-234. 2000.
37. Mahl JA, Vogel BE, Court M, Kolopp M, Roman D, and Nogues V. The minipig in dermatotoxicology: Methods and challenges. Exp Toxicol Pathol. 57: 341-345. 2006.
38. Qvist MH, Hoeck U, Kreilgaard B, Madsen F, and Frokjaer S. Evaluation of Göttingen minipig skin for transdermal in vitro permeation studies. Eur J Pharm Sci. 11: 59-68. 2000.
39. DeLuca L, Beckenstein M, and Guyuron B. Yucatan pig: an optimal hairless model for a true random cutaneous flap. Aesthetic Plast Surg. 21: 205-206. 1997.
40. Hanhijarvi H, Nevalainen T, and Mannisto P. A six month dermal irritation test with anthralins in the Göttingen miniature swine. Arch Toxicol Suppl. 8: 463-468. 1985.
41. Mannisto PT, Hanhijarvi H, Kosma VM, and Collan Y. A 6-month dermal toxicity test with dithranol and butantrone in miniature swine. Contact Dermatitis. 15: 1-9. 1986.
42. Riley KN and Herman IM. Collagenase promotes the cellular responses to injury and wound healing in vivo. J Burns Wounds. 4: 112-124. 2005.
43. Nakashima T, Kato Y, Yamaguchi K, and Oda T. Evaluation of the anti-trichophyton activity of a prodigiosin analogue produced by gamma-proteobacterium, using stratum corneum epidermis of the Yucatan micropig. J Infect Chemother. 11: 123-128. 2005.
44. Gore AV, Liang AC, and Chien YW. Comparative biomembrane permeation of tacrine using Yucatan minipigs and domestic pigs as the animal model. J Pharm Sci. 87: 441-447. 1998.
45. Sambuco CP. Miniature swine as an animal model in photodermatology: factors influencing sunburn cell formation. Photodermatol. 2: 144-150. 1985.
46. Eggleston TA, Roach WP, Mitchell MA, Smith K, Oler D, and Johnson TE. Comparison of two porcine (Sus scrofa domestica) skin models for in vivo near-infrared laser exposure. Comp Med. 50: 391-397. 2000. Comment in: Comp Med. 50: 585. 2000.
47. Bostick AC, Stoffregen DE, and Johnson TE. Response of lightly and highly pigmented porcine skin (Sus scrofa domestica) to single 3.9-microm laser radiation pulses. J Am Assoc Lab Anim Sci. 45: 33-37. 2006.
48. Hamburger SA, Kopaciewicz LJ, and Valocik RE. A new model of myocardial infarction in Yucatan minipigs. J Pharmacol Methods. 25: 291-301. 1991.
49. Koch W, Windt H, Walles M, Borlak J, and Clausing P. Inhalation studies with the Göttingen minipig. Inhal Toxicol. 13: 249-259. 2001.
50. Wargovich MJ, Satterfield W, Price RE, Stephens LC, and Goghlan L. Hepatic pathology of the colon carcinogen, azoxymethane, in Hanford-Moore miniature pigs. J Comp Pathol. 105: 271-278. 1991.
51. Sikov MR, Rommereim DN, Beamer JL, Buschbom RL, Kaune WT, and Phillips RD. Developmental studies of Hanford miniature swine exposed to 60-Hz electric fields. Bioelectromagnetics. 8: 229-242. 1987.
52. Misawa J, Kanda S, Kokue E, Hayama T, Teramoto S, Aoyama H, Kaneda M, and Iwasaki T. Teratogenic activity of pyrimethamine in Göttingen minipig. Toxicol Lett. 10: 51-54. 1982.
53. Jones TC, Hunt RD, and King NW. Diseases due to extraneous poisons. In: Veterinary Pathology, 6th ed. Williams & Wilkins. Baltimore, MD. 695-780. 1997.
54. Tissot RG, Beattie CW, and Amoss MS Jr. Inheritance of Sinclair swine cutaneous malignant melanoma. Cancer Res. 47: 5542-5545. 1987.
55. Amoss MS Jr, Ronan SG, and Beattie CW. Growth of Sinclair swine melanoma as a function of age, histopathological staging, and gonadal status. Cancer Res. 48: 1708-1711. 1988.
56. Vana G and Meingassner JG. Morphologic and immunohistochemical features of experimentally induced allergic contact dermatitis in Göttingen minipig. Vet Pathol. 37: 565-580. 2000.
57. Xi S, Yin W, Wang Z, Kusunoki M, Lian X, Koike T, Fan J, and Zhang Q. A minipig model of high-fat/high-sucrose diet-induced diabetes and atherosclerosis. Int J Exp Pathol. 85: 223-231. 2004.
58. Dixon JL, Stoops JD, Parker JL, Laughlin MH, Weisman GA, and Sturek M. Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet. Arterioscler Thromb Vasc Biol. 19: 2981-2992. 1999.
59. Sebert SP, Lecannu G, Sene S, Hucteau S, Chetiveaux M, Ouguerram K, and Champ MM. Obesity induced during sexual maturation is linked to LDL-triacylglycerols in Yucatan miniature swine. Br J Nutr. 94: 282-289. 2005.
60. Johansen T, Hansen HS, Richelsen B, and Malmlof R. The obese Göttingen minipig as a model of the metabolic syndrome: dietary effects on obesity, insulin sensitivity, and growth hormone profile. Comp Med. 51: 150-155. 2001.
61. Misfeldt ML and Grimm DR. Sinclair miniature swine: an animal model of human melanoma. Vet Immunol Immunopathol. 43: 167-175. 1994.